You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Colorectal cancer

Aflibercept in combination with irinotecan and fluorouracil-based therapy for treating metastatic colorectal cancer that has progressed following prior oxaliplatin-based chemotherapy

  • Technology appraisal guidance
  • Reference number: TA307
  • Published:  25 March 2014
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Colorectal cancer (metastatic) - aflibercept: Appendix C - provisional matrix (pre-referral) - September 2011

Colorectal cancer (metastatic) - aflibercept: Appendix C - provisional matrix (pre-referral) - September 2011 Colorectal cancer (metastatic) - aflibercept: Appendix C - provisional matrix (pre-referral) - September 2011
21 March 2012
(106.49 Kb 31 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 21 March 2012

Back to top